Dr. Ostrander is Chief of the Cancer Genetics Branch at the National Human Genome Research Institute of NIH where she also heads the Section of Comparative Genetics. She received her PhD from the Oregon Health Sciences University, and did her postdoc training at Harvard. Ostrander then went to Berkeley, where she began her work in sequencing the canine genome, and worked also at the Lawrence Berkeley National Labs on the Human Genome Project. She then conducted studies at the Fred Hutchinson Cancer Research Center and University of Washington for 12 years, rising to the rank of Member in the Human Biology and Clinical Research Divisions, and Head of the Genetics Program.
Her current research interests are in the area of genetic mapping and genomics. Her lab works in both human and canine genetics and focuses on diseases associated with complex underlying genetics such as cancer and hip dysplasia.
“Elaine is a true pioneer in the discovery and mapping of the canine genome – an invaluable tool in the fight against disease,” noted Wayne Ferguson, then-president of the CHF. “The Directors of the Foundation realized early on the potential of the genome sequence and made this a top funding priority. Discoveries by funded investigators led to a landmark $50 million study of the canine genome by the National Institutes of Health – and, without it, I believe we would not have seen nearly as much progress in this short amount of time.”
Upon accepting the award, Dr. Ostrander noted, “This is truly one of the most prestigious honors I’ve received. Asa Mays was an amazing man who left this world far too soon. He was dedicated to canine health in so many ways; a visionary and a leader.” Dr. Ostrander continued, “I am so proud to be the first recipient of this award. On behalf of my many collaborators as well as all of the breed clubs that have generously shared their dogs DNA and their personal stories with me over the years, I say thank you. My challenge now is to live up to your expectations. I will continue to do my best.”